| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66ef19b084f6518ad94cd0b4dc7e7df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdb344a62e20172339264d2c28f6f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c7b68bc553510b627ccf85d8f7fe06 |
| publicationDate |
1998-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2254925-A1 |
| titleOfInvention |
Drugs for relieving diabetic vascular lesion |
| abstract |
Drugs for relieving diabetic vascular lesion which contain as the active ingredient prostaglandin derivatives typified for example by beraprost; and a method for preventing or treating diabetic vascular lesion with the use of the same. These drugs exert excellent effect of inhibiting diabetic vascular lesion when administered not only orally but also parenterally. |
| priorityDate |
1997-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |